- Report
- May 2022
- 231 Pages
Global
From €4609EUR$4,799USD£3,968GBP
- Report
- May 2021
- 381 Pages
Global
From €4609EUR$4,799USD£3,968GBP
- Report
- May 2022
- 365 Pages
Global
From €4609EUR$4,799USD£3,968GBP
- Report
- April 2020
- 248 Pages
Global
From €4705EUR$4,899USD£4,051GBP
- Report
- November 2019
- 403 Pages
Global
From €4321EUR$4,499USD£3,720GBP
- Report
- October 2022
- 194 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- November 2020
- 217 Pages
Global
From €3842EUR$4,000USD£3,308GBP
- Report
- September 2022
- 110 Pages
Global
From €5283EUR$5,500USD£4,548GBP
- Report
- June 2021
- 141 Pages
Global
From €2641EUR$2,750USD£2,274GBP
€5283EUR$5,500USD£4,548GBP
- Report
- March 2021
- 229 Pages
Global
From €4010EUR$4,175USD£3,452GBP
- Report
- January 2023
- 343 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- April 2020
- 108 Pages
Global
From €1153EUR$1,200USD£992GBP
- Report
- May 2024
- 262 Pages
From €5379EUR$5,600USD£4,631GBP
- Report
- May 2019
- 60 Pages
Global
From €4754EUR$4,950USD£4,093GBP
- Report
- March 2022
- 198 Pages
Global
From €3059EUR$3,185USD£2,634GBP
€4370EUR$4,550USD£3,762GBP
- Report
- March 2019
- 142 Pages
North America
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- June 2019
- 154 Pages
Europe
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- June 2019
- 152 Pages
Asia Pacific
From €2017EUR$2,100USD£1,736GBP
€2881EUR$3,000USD£2,481GBP
- Report
- July 2022
- 100 Pages
Global
From €2641EUR$2,750USD£2,274GBP
- Report
- August 2022
- 105 Pages
Global
From €4562EUR$4,750USD£3,928GBP
Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more